Know Cancer

or
forgot password

FDG-PET/CT in the Diagnosis and Monitoring of Psoriatic Arthritis


N/A
18 Years
80 Years
Open (Enrolling)
Both
Psoriatic Arthritis

Thank you

Trial Information

FDG-PET/CT in the Diagnosis and Monitoring of Psoriatic Arthritis


Inclusion Criteria:



- Age 18-80,

- active psoriatic arthritis (joint or enthesis inflammation)

Exclusion Criteria:

- Diabetes,

- pregnant,

- no active PsA

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Principal Investigator

Alexis R Ogdie, MD, MSCE

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Pennsylvania

Authority:

United States: Food and Drug Administration

Study ID:

815253

NCT ID:

NCT01654198

Start Date:

July 2012

Completion Date:

May 2013

Related Keywords:

  • Psoriatic Arthritis
  • Arthritis
  • Arthritis, Psoriatic

Name

Location

University of Pennsylvania Division of RheumatologyPhiladelphia, Pennsylvania  19104